MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$149,390K
Net Income
$63,742K
Net Profit Margin
42.67%
EPS
$0.5
Unit: Thousand (K) dollars
Revenue Breakdown
    • Firdapse
    • Agamree
    • Fycompa
    • License And Other Revenue
Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenues
149,390
152,613
148,392
146,563
Cost of sales
14,475
26,074
22,654
20,614
Research and development
2,661
1,807
2,657
4,358
Selling, general and administrative
49,319
53,421
47,470
45,949
Amortization of intangible assets
9,703
9,465
9,344
9,344
Total operating costs and expenses
76,158
90,767
82,125
80,265
Operating income
73,232
61,846
66,267
66,298
Other income, net
10,997
10,055
4,768
2,995
Net income before income taxes
84,229
71,901
71,035
69,293
Income tax provision
20,495
19,203
18,252
17,185
Net income
63,734
52,698
52,783
52,108
Unrealized gain (loss) on available-for-sale securities, net of tax of (3) and 25, respectively
8
0
-31
48
Comprehensive income
63,742
52,698
52,752
52,156
Basic EPS
0.52
0.429
0.43
0.43
Diluted EPS
0.5
0.414
0.42
0.41
Basic Average Shares
122,254,171
122,927,054
122,600,730
122,163,212
Diluted Average Shares
126,903,391
127,440,256
127,090,194
127,543,284
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Firdapse$98,859K Agamree$36,713K Fycompa$13,771K Product Revenue Net$149,343K License And OtherRevenue$47K Total revenues$149,390K (5.63%↑ Y/Y)Operating income$73,232K (15.57%↑ Y/Y)Other income, net$10,997K (38.87%↑ Y/Y)Total operating costsand expenses$76,158K (-2.43%↓ Y/Y)Net income beforeincome taxes$84,229K (18.16%↑ Y/Y)Selling, general andadministrative$49,319K (5.13%↑ Y/Y)Cost of sales$14,475K (-19.18%↓ Y/Y)Amortization of intangibleassets$9,703K (3.83%↑ Y/Y)Research and development$2,661K (-31.54%↓ Y/Y)Net income$63,734K (12.33%↑ Y/Y)Unrealized gain (loss) onavailable-for-sale securities, net...$8K (109.88%↑ Y/Y)Income tax provision$20,495K (40.87%↑ Y/Y)Comprehensive income$63,742K (12.51%↑ Y/Y)

CATALYST PHARMACEUTICALS, INC. (CPRX)

CATALYST PHARMACEUTICALS, INC. (CPRX)